Editorial: Immune response to SARS-CoV-2 and implications for clinical outcome

Edwin Bölke; Martijn van Griensven; E. Marion Schneider; Johannes C. Fischer; Torsten Feldt; Verena Keitel; Wilfried Budach; Jan Haussmann; Danny Jazmati; Christiane Matuschek

doi:10.3389/fimmu.2023.1233291

Editorial: Immune response to SARS-CoV-2 and implications for clinical outcome

Edwin Bölke, Martijn van Griensven, E. Marion Schneider, Johannes C. Fischer, Torsten Feldt, Verena Keitel, Wilfried Budach, Jan Haussmann, Danny Jazmati, Christiane Matuschek

Publikation: Beitrag in Fachzeitschrift › Leitartikel

Originalsprache	Englisch
Aufsatznummer	1233291
Fachzeitschrift	Frontiers in Immunology
Jahrgang	14
DOIs	https://doi.org/10.3389/fimmu.2023.1233291
Publikationsstatus	Veröffentlicht - 2023
Extern publiziert	Ja

Zugriff auf Dokument

10.3389/fimmu.2023.1233291

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{ab944c04256e4fed8d7b0647ca3372fb,

title = "Editorial: Immune response to SARS-CoV-2 and implications for clinical outcome",

keywords = "COVID - 19, cytokine, inflammation, pandemic, sepsis",

author = "Edwin B{\"o}lke and {van Griensven}, Martijn and Schneider, {E. Marion} and Fischer, {Johannes C.} and Torsten Feldt and Verena Keitel and Wilfried Budach and Jan Haussmann and Danny Jazmati and Christiane Matuschek",

note = "Funding Information: Res-Q-HR funding was obtained from the German Ministry of Health for CM, EB, JF, TF and VK regarding SARS-CoV-2.",

year = "2023",

doi = "10.3389/fimmu.2023.1233291",

language = "English",

volume = "14",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Editorial

T2 - Immune response to SARS-CoV-2 and implications for clinical outcome

AU - Bölke, Edwin

AU - van Griensven, Martijn

AU - Schneider, E. Marion

AU - Fischer, Johannes C.

AU - Feldt, Torsten

AU - Keitel, Verena

AU - Budach, Wilfried

AU - Haussmann, Jan

AU - Jazmati, Danny

AU - Matuschek, Christiane

N1 - Funding Information: Res-Q-HR funding was obtained from the German Ministry of Health for CM, EB, JF, TF and VK regarding SARS-CoV-2.

PY - 2023

Y1 - 2023

KW - COVID - 19

KW - cytokine

KW - inflammation

KW - pandemic

KW - sepsis

UR - http://www.scopus.com/inward/record.url?scp=85165613404&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2023.1233291

DO - 10.3389/fimmu.2023.1233291

M3 - Editorial

AN - SCOPUS:85165613404

SN - 1664-3224

VL - 14

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1233291

ER -